Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received February 12, 2020
- Revision received February 26, 2020
- Accepted February 27, 2020
- Published online March 31, 2020.
Copyright & Usage
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
Author Information
- DAICHI WATANABE1,
- HIRONORI FUJII1⇑,
- NOBUHISA MATSUHASHI2,
- HIROTOSHI IIHARA1,
- YUNAMI YAMADA1,
- TAKUMA ISHIHARA3,
- TAKAO TAKAHASHI2,4,
- KAZUHIRO YOSHIDA2 and
- AKIO SUZUKI1
- 1Department of Pharmacy, Gifu University Hospital, Gifu, Japan
- 2Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, Japan
- 3Gifu University Hospital, Innovative and Clinical Research Promotion Center, Gifu University, Gifu, Japan
- 4Department of Frontier Science for Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, Japan
- Correspondence to: Hironori Fujii, Department of Pharmacy, Gifu University Hospital, Yanagido 1-1, Gifu 501-1194, Japan. Tel: +81 582307080, Fax: +81 582307093, e-mail: h_fujii{at}gifu-u.ac.jp
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Identification Drug Targets for Oxaliplatin-Induced Cardiotoxicity without Affecting Cancer Treatment through Inter Variability Cross-Correlation Analysis (IVCCA)
- Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer
- Oxaliplatin-induced cardiotoxicity in mice is connected to the changes in energy metabolism in the heart tissue
- Oxaliplatin-induced cardiotoxicity in mice is connected to the changes in energy metabolism in the heart tissue